Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. R. Zile"'
Autor:
J. J. Lancaster, A. Grijalva, J. Fink, J. Ref, S. Daugherty, S. Whitman, K. Fox, G. Gorman, L. D. Lancaster, R. Avery, T. Acharya, A. McArthur, J. Strom, M. K. Pierce, T. Moukabary, M. Borgstrom, D. Benson, M. Mangiola, A. C. Pandey, M. R. Zile, A. Bradshaw, J. W. Koevary, S. Goldman
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-14 (2023)
Abstract There are nearly 65 million people with chronic heart failure (CHF) globally, with no treatment directed at the pathologic cause of the disease, the loss of functioning cardiomyocytes. We have an allogeneic cardiac patch comprised of cardiom
Externí odkaz:
https://doaj.org/article/fa79a0230faf4eef89464cb617bedea6
Autor:
P Tolomeo, T Kondo, J H Butt, A S Desai, M P Lefkowitz, J L Rouleau, S D Solomon, K Swedberg, M R Zile, G Campo, P S Jhund, M Packer, J J V McMurray
Publikováno v:
European Heart Journal. 43
Background Estimated glomerular filtration rate (eGFR) is a key determinant of eligibility for many life-saving therapies in HFrEF. Recently, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) provided new equations based on creatinine (
Autor:
K McDowell, J Simpson, P S Jhund, W T Abraham, B Claggett, J Cunningham, A S Desai, L Kober, M Prescott, J L Rouleau, K Swedberg, M R Zile, S D Solomon, M Packer, J J V McMurray
Publikováno v:
European Heart Journal. 43
Background Although multiple novel biomarkers have individually been shown to predict outcomes in patients with HFrEF, the value of these over and above conventional clinical and laboratory variables, plus natriuretic peptides, is uncertain. Purpose
Autor:
J Curtain, C Adamson, P S Jhund, A S Desai, M P Lefkowitz, A R Rizkala, J L Rouleau, K Swedberg, M R Zile, S D Solomon, M Packer, J J V McMurray
Publikováno v:
European Heart Journal. 43
Background Anaemia is common in patients with HFrEF and is associated with poor clinical outcomes. Although they reduce rates of mortality and heart failure hospitalization, renin-angiotensin (RAS) blockers lower haemoglobin and may induce anaemia. C
Autor:
M R Zile
Publikováno v:
Aktuelle Kardiologie. 6:96-97
Autor:
William H. Gaasch, M. R. Zile
Publikováno v:
European Heart Journal. 12:48-51
It is generally believed that mitral regurgitation (MR) creates a systolic 'unloading' effect by providing a low-resistance ejection into the left atrium; this is thought to increase the left ventricular ejection fraction (EF), and thus to mask a red
Autor:
M R, Zile
Publikováno v:
Minerva cardioangiologica. 51(2)
It is now abundantly clear that congestive heart failure caused by a predominant abnormality in diastolic function (i.e., diastolic heart failure) is common and causes a significant increase in morbidity and mortality. However, there is continued con
Publikováno v:
Circulation. 84(3)
BACKGROUND To assess and compare the energy demands of normal and hypertrophic hearts, we defined the relation between myocardial oxygen consumption (MVO2, an index of the energy consumed by contraction) and the left ventricular pressure-volume area
Publikováno v:
The American journal of cardiology. 51(3)